Ulisse Biomed Spa
MIL:UBM
Cash Flow Statement
Cash Flow Statement
Ulisse Biomed Spa
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
3
|
4
|
3
|
3
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
0
|
0
|
2
|
1
|
(1)
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-206%
|
(1)
+20%
|
(1)
-44%
|
(1)
+35%
|
(2)
-126%
|
(4)
-74%
|
(3)
+26%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
+16%
|
(0)
+72%
|
(0)
+40%
|
(0)
+28%
|
(0)
+72%
|
(0)
-6%
|
(0)
-194%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
6
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Cash from Financing Activities |
6
N/A
|
6
+0%
|
0
-100%
|
0
-32%
|
0
N/A
|
0
N/A
|
2
+478%
|
3
+12%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
5
N/A
|
4
-13%
|
(1)
N/A
|
(2)
-28%
|
(1)
+34%
|
(2)
-67%
|
(1)
+24%
|
(0)
+87%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(1)
N/A
|
(2)
-47%
|
(1)
+40%
|
(2)
-28%
|
(1)
+34%
|
(2)
-107%
|
(4)
-73%
|
(3)
+24%
|
|